Selectively increased growth of fetal hemoglobin-expressing adult erythroid progenitors after brief treatment of early progenitors with transforming growth factor beta

Blood

Volumn 95, Issue 9, 2000, Pages 2967-2974

  Bohmer, Ralph M ^a   Campbell, Thomas A ^b   Bianchi, Diana W ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN F; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CELL DIVISION; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0034192224     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.9.2967.009k21_2967_2974     Document Type: Article

References (30)

1. Stamatoyannopoulos B, Rosenblum BB, Papayannopoulou T, Brice M, Nakamoto B, Shepard TH. HbF and HbA production in erythroid cultures from human tetuses and neonates. Blood. 1979; 54:440.
2. Bohmer RM, Zhen DK, Bianchi DW. Differential development of fetal and adult haemoglobin profiles in colony culture: isolation of fetal nucleated red cells by two-color fluorescence labeling. Br J Haematol. 1998;103:351-360.
3. Papayannopoulou T, Nakamoto B, Buckley J, Kurachi S, Nute PE, Stamatoyannopoulos G. Erythroid progenitors circulating in the blood of adult individuals produce fetal hemoglobin in culture. Science. 1978;199:1349.
4. Papayannopoulou T, Kurachi S, Nakamoto B, Zanjani ED, Stamatoyannopoulos G. Hemoglobin switching in culture: evidence for a humoral factor that induces switching in adult and neonatal but not fetal erythroid cells. Proc Natl Acad Sci U S A. 1982;79:6579.
5. Migliaccio AR, Migliaccio G, Brice W, Constantoulakis P, Stamatoyannopoulos G, Papayannopulou T. Influence of recombinant hemopoietin and of fetal bovine serum on the globin synthetic pattern of human BFUe. Blood. 1990;76:1150.
6. Constantoulakis P, Nakamoto B, Papayannopoulou T, Stamatoyannopoulos G. Fetal calf serum contains activities that induce fetal hemoglobin in adult erythroid cell cultures. Blood. 1990;75:1862.
7. Rosenblum B, Strahler J, Hauash S, Whitten C, Butkunas-Puskorius R, Roberts A. Peripheral blood erythroid progenitors from patients with sickle cell anemia: HPLC separation of hemoglobin and the effect of a HbF switching factor. In: Stamatoyannopoulos G, Nienhuis AW, eds. Experimental Approaches for the Study of Hemoglobin Switching. New York, NY: Liss; 1985;397.
8. Jane SM, Cunningham JM. Understanding fetal globin gene expression: a step towards effective HbF reactivation in haemoglobinopathies. Br J Haematol. 1998;102:415-422.
9. Olivieri NF. Reactivation of fetal hemoglobin in patients with beta-thalassemia. Semin Hematol. 1996;33:24-42.
10. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997;337:762-769.
11. DeSimone J, Heller P, Hall L, Zwiers D. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc Natl Acad Sci U S A. 1982; 79:4428-4431.
12. Ley TJ, DeSimone J, Noguchi CR, et al. 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia. Blood. 1983;62:370-380.
13. Carache S, Terrin ML, Morre RD. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med. 1995;332:1317-1322.
14. Perrine SP, Glinder GD, Faller DV. A short-term trial of butyrate to stimulate fetal globin gene expression in the beta-globin disorders. N Engl J Med. 1993;328:81-86.
15. Perrine SP, Olivieri NF, Faller DV. Butyrate derivatives: new agents for stimulating fetal globin production in the beta-globin disorders. Am J Pediatr Hemtol Oncol. 1994;16:67-71.
16. Dybedal I, Jacobsen SE. Transforming growth factor beta (TGF-beta), a potent inhibitor of erythropoiesis: neutralizing TGF-beta antibodies show erythropoietin as a potent stimulator of murine burst-forming unit erythroid colony formation in the absence of a burst-promoting activity. Blood. 1995;86:949-957.
17. Krystal G, Lam V, Dragowska W, et al. Transforming growth factor beta 1 is an inducer of erythroid differentiation. J Exp Med. 1994;180:851-860.
18. Leveque E, Nagel MD, Haye B. Effect of the interaction between transforming growth factor beta and erythropoietin on the proliferation of normal erythroid progenitors and leukaemic UT-7 cells: action of transforming growth factor beta on the erythropoietin receptor. Hematol Oncol. 1996;14: 137-146.
19. Chen LL, Dean A, Jenkinson T, Mendelsohn J. Effect of transforming growth factor beta 1 on proliferation and induction of hemoglobin accumulation in K-562 cells. Blood. 1989;74:2368.
20. Hooper WC, Pruckler J, Jackson D, Evatt BL. Transforming growth factor-beta induces hemoglobin synthesis in a human erythroleukemia cell line. Biochem Biophys Res Commun. 1989;165: 145.
21. Miller KL, Carlino JA, Ogawa Y, Avis PD, Carroll KG. Alterations in erythropoiesis in TGF-beta 1-treated mice. Exp Hematol. 1992;20:951-956.
22. Chuncharunee S, Carter CD, Studtmann KE, Caro J, Coffey RJ, Dessypris EN. Chronic administration of transforming growth factor-beta suppresses erythropoietin-dependent erythropoiesis and induces tumour necrosis factor in vivo. Br J Haematol. 1993;84:374-380.
23. Goey H, Keller JR, Back T, Longo DL, Ruscette FW, Wiltrout RH. Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-beta1. J Immunol. 1989;143:877-880.
24. Croizat H, Nagel RL. Circulating cytokines response and the level of erythropoiesis in sickle cell anemia. Am J Hematol. 1999;60:105-115.
25. Bohmer RM. Two-step cell-death kinetics in vitro during cis-platinum, hydroxyurea and mitomycin incubation. Cell Tissue Kinet. 1984;17:593.
26. Bohmer RM. Flow cytometry of erythropoiesis in culture: bivariate profiles of fetal and adult hemoglobin. In: Darzynkiewicz Z, Robinson JP, Crissman HA, eds. Methods in Cell Biology. Cytometry. 3rd ed. San Diego, CA: Academic Press; 2000. In press.
27. Bohmer RM, Zhen DK, Bianchi DW. Identification of fetal nucleated red cells in co-cultures from fetal and adult peripheral blood: differential effects of serum on fetal and adult erythropoiesis. Prenat Diagn. 1999;19:628.
28. Ou CN, Rognerud CL. Rapid analysis of hemoglobin variants by HPLC. Clin Chem. 1993;39: 820.
29. Sansilvestri P, Cardoso AA, Batard P, et al. Early CD34 high cells can be separated into KIThigh cells in which transforming growth factor-beta (TGF-beta) downmodulates c-kit and KITlow cells in which anti-TGF-beta upmodulates c-kit. Blood. 1995;86:1729-1735.
30. Lardon F, Snoeck HW, Nijs G, et al. Transforming growth factor-beta regulates the celi cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor, or IL-6 stimulated CD34+ human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus. Exp Hematol. 1994;22:903-909.